Back to dataset

FLS-DB 2023 clinical dataset barnadised

The Fracture Liaison Service Database (FLS-DB) January to December 2023

You're previewing the first 4 rows of this file.

flscode	FLS name	Data completeness	Total submitted	Total submitted (spine)	Total submitted (hip)	Total submitted (non-hip, non spine)	Percentage submitted (spine)	Percentage submitted (hip)	Percentage submitted (non-hip, non-spine)	Total submitted (under 75)	Total submitted (over 75)	Estimated caseload	Percentage of estimated caseload submitted (all patients)	Percentage of estimated caseload submitted (under 75)	Percentage of estimated caseload submitted (over 75)	Number assessed within 90 days (all patients)	Percentage assessed within 90 days	Number DXA within 90 days (all patients)	Percentage DXA within 90 days (all patients)	Number receiving a falls assessment (all patients)	Number receiving a falls assesment (under 75)	Number receiving a falls assessment (over 75)	Percentage receiving a falls assessment (all patients)	Percentage receiving a falls assessment (under 75)	Percentage receiving a falls assessment (over 75)	Number of patients with a treatment recommendation (all patients)	Number of patients with a treatment recommendation (under 75)	Number of patients with a treatment recommendation (over 75)	Percentage of patients with a treatment recommendation (all patients)	Percentage of patients with a treatment recommendation (under 75)	Percentage of patients with a treatment recommendation (over 75)	Oral bisphosphonates - %	Total number of patients receiving bisphosphonates	Zoledronate - %	Total number of patients receiving zoledronate	Denosumab - %	Total number of patients receiving denosumab	Raloxifene - %	Total number of patients receiving raloxifene	Teriparatide - %	Total number of patients receiving teriparatide	Romosozumab - %	Total number of patients receiving romosozumab	Referred to GP - %	Total number of patients referred to a GP	Referred for clinical opinion %	Total number of patients referred for clinical opinion	Number of patients due follow up (non-hip fracture)	Number of patients due follow up (non-hip fracture patients) (under 75)	Number of patients due follow up (non-hip fracture patients) (over 75)	Percentage of patients due follow up (non-hip fracture)	Number of patients due follow up (all patients)	Number of patients started strength and balance (non hip fracture)	Number of patients started strength and balance (non-hip fracture) (under 75)	Number of patients started strength and balance (non-hip fracture) (over 75)	Percentage of patients started strength and balance (non hip fracture)	Percentage of patients started strength and balance (non-hip fracture) (under 75)	Percentage of patients started strength and balance (non-hip fracture) (over 75)	Number of patients due follow up (Hip fracture patients)	Number of patients followed up (all fractures)	Number of patients followed up (hip fractures)	Number of patients followed up (non-hip fractures)	Percentage of patients followed up (all fractures)	Percentage of patients followed up (hip fractures)	Percentage of patients followed up (non-hip fractures)	Number of patients commenced bone therapy by 1st follow up	Percentage of patients commenced bone therapy by 1st follow up	Total number of patients receiving oral bisphosphonates	Oral bisphosphonates %	Total number of patients receiving zoledronate	Zoledronate %	Total number of patients receiving denosumab	Denosumab %	Total number of patients receiving raloxifene	Raloxifene %	Total number of patients receiving teriparatide	Teriparatide %	Total number of patients receiving romosozumab	Romosozumab %	Total number of patients referred to GP	Referred to GP %	Total number of patients referred for clinical opinion	Referred for clinical opinion %	Number of patients due follow up at 1 year	Number adherent to bone therapy at 12 months	Percentage of patients adherent to bone therapy at 12 months	Total number of patients receiving bisphosphonates	oral bisphosphonates %	Total number of patients receiving zoledronate	zoledronate %	Total number of patients receiving denosumab	denosumab %	Total number of patients receiving raloxifene	raloxifene %	Total number of patients receiving teriparatide	Teriparatide %	Total number of patients receiving romosozumab	Romosozumab %	Total number of patients referred to GP	Referred to GP %	Total number of patients referred for clinical opinion	Referred for clinical opinion %
AIR	AIREDALE NHS FOUNDATION TRUST	80	879	126	279	600	47	32	68	422	457	1068	82	79	86	933	93	32	5	848	411	437	84	87	82	525	166	359	52	35	67	17	89	49	257	5	28	0	0	0	0	2	10	4	23	22	118	282	128	154	46	488	26	*	26	9	*	16	206	225	172	53	46	83	19	342	70	87	18	206	42	28	6	0	0	*	*	*	*	0	0	0	0	370	312	84	136	37	103	28	16	4	*	*	*	*	14	4	0	0	0	0
NEV	ANEURIN BEVAN UNIVERSITY HEALTH BOARD	60	1805	359	859	946	47	48	52	606	1199	3049	59	40	79	1632	75	77	13	1526	324	1202	71	45	83	1429	316	1113	66	44	77	34	493	34	479	16	226	0	0	*	*	1	11	1	12	15	217	666	167	499	57	1332	112	24	112	17	14	18	666	758	477	281	57	72	42	683	51	287	22	213	16	108	8	0	0	0	0	*	*	0	0	0	0	1008	184	18	77	8	27	3	35	3	0	0	0	0	0	0	0	0	0	0
SPH	ASHFORD AND ST PETER'S HOSPITALS NHS FOUNDATION TRUST	70	644	91	*	640	24	*	99	368	276	1489	43	49	37	689	94	132	26	735	398	337	100	100	100	402	155	247	55	39	73	67	269	*	*	17	67	0	0	0	0	0	0	10	40	5	22	399	155	244	0	401	0	0	0	0	0	0	*	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	295	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
BNT	BARNET HOSPITAL	100	443	176	169	274	55	38	62	154	289	1275	35	24	45	595	96	166	72	582	168	414	94	93	95	300	90	210	48	50	48	53	160	22	66	*	*	0	0	0	0	0	0	6	18	15	46	196	69	127	94	284	12	*	12	6	*	9	88	268	84	184	94	95	94	215	76	103	36	59	21	*	*	0	0	0	0	0	0	0	0	0	0	352	255	72	125	36	40	11	*	*	0	0	0	0	0	0	0	0	0	0